Indications And Dose
Motion sickness ▶BY MOUTH ▶Child 4–9 years: 75–150 micrograms, dose to be taken up to 30 minutes before the start of journey, then 75–150 micrograms every 6 hours if required; maximum 450 micrograms per day ▶Child 10–17 years: 150–300 micrograms, dose to be taken up to 30 minutes before the start of journey, then 150–300 micrograms every 6 hours if required; maximum 900 micrograms per day ▶Adult: 150–300 micrograms, dose to be taken up to 30 minutes before the start of journey, then 150–300 micrograms every 6 hours if required; maximum 900 micrograms per day ▶BY TRANSDERMAL APPLICATION ▶Child 10–17 years: Apply 1 patch, apply behind ear 5–6 hours before journey, then apply 1 patch after 72 hours if required, remove old patch and site replacement patch behind the other ear ▶Adult: Apply 1 patch, apply behind ear 5–6 hours before journey, then apply 1 patch after 72 hours if required, remove old patch and site replacement patch behind the other ear Hypersalivation associated with clozapine therapy ▶BY MOUTH ▶Adult: 300 micrograms up to 3 times a day; maximum 900 micrograms per day Excessive respiratory secretion in palliative care ▶BY SUBCUTANEOUS INJECTION ▶Adult: 400 micrograms every 4 hours as required, hourly use is occasionally necessary, particularly in excessive respiratory secretions ▶BY CONTINUOUS SUBCUTANEOUS INFUSION ▶Adult: 1.2–2 mg/24 hours Bowel colic in palliative care ▶BY SUBCUTANEOUS INJECTION ▶Adult: 400 micrograms every 4 hours as required, hourly use is occasionally necessary ▶BY SUBCUTANEOUS INFUSION ▶Adult: 1.2–2 mg/24 hours Bowel colic pain in palliative care ▶BY MOUTH USING SUBLINGUAL TABLETS ▶Adult: 300 micrograms 3 times a day, as Kwells ®. Premedication ▶BY SUBCUTANEOUS INJECTION, OR BY INTRAMUSCULAR INJECTION ▶Adult: 200–600 micrograms, to be administered 30–60 minutes before induction of anaesthesia l UNLICENSED USE Not licensed for hypersalivation associated with clozapine therapy.
PDF pages 480, 481